The death of Carmen Duncan, an acclaimed Australian actress, has sparked a powerful movement for gynaecological cancer research. Paula Duncan, Carmen's sister, is leading a heartfelt campaign to raise funds for life-saving research into gynaecological cancers, which remain among the most underfunded areas of cancer research. Despite medical advances, outcomes for many gynaecological cancers have barely improved in decades, with vaginal cancer having a five-year survival rate of just 53.6 per cent. This figure has seen little improvement in more than three decades, highlighting the urgent need for action. The Venus Mother's Day Lunch event, hosted by Jean Kittson, is a crucial initiative that combines expert insight, lived experiences, and community action to raise critical funds for research across all gynaecological cancers. The event features a panel discussion, 'Cause and Effect of Vaginal and Vulval Cancer,' with leading experts and advocates, including Professor Alison Brand AM and survivor advocate Jane Hancox. The campaign has already raised over $150,000, demonstrating strong community support, but more is needed to drive meaningful change. This movement is a testament to the power of personal tragedy to inspire collective action, and it is a call to arms for everyone to support gynaecological cancer research. In my opinion, this campaign is a crucial step towards improving the outcomes for women affected by gynaecological cancers, and it highlights the importance of continued investment in cancer research. The low funding for gynaecological cancer research is a systemic issue that has contributed to the poor survival rates for these cancers. It is a stark reminder that we must continue to advocate for increased funding and support for cancer research, as well as for the development of new treatments and therapies. The campaign also raises a deeper question about the impact of personal experiences on public policy and research priorities. It is a powerful reminder that the voices of those affected by cancer should be at the forefront of research and policy-making. The campaign is a call to action for everyone to support the Gynaecological Cancer Transformation Initiative (GCTI), which is working to address decades of systemic underinvestment and deliver better outcomes for future generations. The GCTI's mission is to improve the outcomes and quality of life for everyone with a lived experience of gynaecological cancer by conducting and promoting clinical trials and multidisciplinary research. The campaign is a testament to the power of personal tragedy to inspire collective action, and it is a call to arms for everyone to support gynaecological cancer research. In my opinion, this campaign is a crucial step towards improving the outcomes for women affected by gynaecological cancers, and it highlights the importance of continued investment in cancer research. The low funding for gynaecological cancer research is a systemic issue that has contributed to the poor survival rates for these cancers. It is a stark reminder that we must continue to advocate for increased funding and support for cancer research, as well as for the development of new treatments and therapies. The campaign also raises a deeper question about the impact of personal experiences on public policy and research priorities. It is a powerful reminder that the voices of those affected by cancer should be at the forefront of research and policy-making. The campaign is a call to action for everyone to support the Gynaecological Cancer Transformation Initiative (GCTI), which is working to address decades of systemic underinvestment and deliver better outcomes for future generations.
